Dr Reddy’s Labs to change drug name to 'Olymra' amid court scrutiny: Report
NEW DELHI: Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from 'Olymviq' to 'Olymra', a report said on Friday.
The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.
The dispute comes as India opens up to generic versions of semaglutide following patent expiry, triggering competition among drugmakers and disputes over branding.
The company also said it is the first Indian firm to receive approval from the Drugs Controller General of India for generic semaglutide.
The case centres on whether 'Olymviq' is too similar to 'Ozempic', a widely used drug for diabetes and weight management, as per NDTV Profit.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
